202 related articles for article (PubMed ID: 27035821)
1. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
[TBL] [Abstract][Full Text] [Related]
2. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
[TBL] [Abstract][Full Text] [Related]
3. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
Bancone G; Chu CS; Chowwiwat N; Somsakchaicharoen R; Wilaisrisak P; Charunwatthana P; Bansil P; McGray S; Domingo GJ; Nosten FH
Am J Trop Med Hyg; 2015 Apr; 92(4):818-824. PubMed ID: 25646252
[TBL] [Abstract][Full Text] [Related]
4. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
[TBL] [Abstract][Full Text] [Related]
6. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
[TBL] [Abstract][Full Text] [Related]
7. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
[TBL] [Abstract][Full Text] [Related]
8. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
[TBL] [Abstract][Full Text] [Related]
10. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
11. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
[TBL] [Abstract][Full Text] [Related]
12. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
[TBL] [Abstract][Full Text] [Related]
14. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.
Aung TH; Suansomjit C; Tun ZM; Hlaing TM; Kaewkungwal J; Cui L; Sattabongkot J; Roobsoong W
Malar J; 2023 May; 22(1):143. PubMed ID: 37127600
[TBL] [Abstract][Full Text] [Related]
17. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
18. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
[TBL] [Abstract][Full Text] [Related]
19. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
[TBL] [Abstract][Full Text] [Related]
20. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
